Clinical Trial Update: Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of Histogen's Hair Stimulating Complex (HSC) for female pattern hair loss (androgenetic alopecia).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia
• Androgenetic Alopecia

Drugs mentioned

• Hair Stimulating Complex (HSC)

Snippet

Sponsor: Histogen | Conditions: Alopecia | Phase 1 | Status: UNKNOWN